Patents by Inventor Lucile Warter

Lucile Warter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chikungunya virus antigen constructs
    Patent number: 11649467
    Abstract: The invention provides adenoviral vectors comprising transgenes encoding Chikungunya virus antigens. The vectors can be used to produce vaccines for the prophylaxis, amelioration and treatment of diseases caused by Chikungunya virus infections.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: May 16, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Benjamin Wizel, Martine Harvey, Lucile Warter, Kate Luisi
  • CHIKUNGUNYA VIRUS ANTIGEN CONSTRUCTS
    Publication number: 20200172930
    Abstract: The invention provides adenoviral vectors comprising transgenes encoding Chikungunya virus antigens. The vectors can be used to produce vaccines for the prophylaxis, amelioration and treatment of diseases caused by Chikungunya virus infections.
    Type: Application
    Filed: July 19, 2018
    Publication date: June 4, 2020
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Benjamin WIZEL, Martine HARVEY, Lucile WARTER, Kate LUISI
  • Binding molecules against Chikungunya virus and uses thereof
    Patent number: 9738704
    Abstract: The invention relates to binding molecules against Chikungunya virus, which are able of neutralizing Chikungunya virus infectivity, and which can be used with therapeutic, diagnosis or research purposes, as well as to a pharmaceutical composition comprising said binding molecules.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: August 22, 2017
    Assignee: Agency for Science, Technology and Research
    Inventors: Lucile Warter, Jean-Pierre Abastado, Alessandra Nardin, Cheng-I Wang
  • BINDING MOLECULES AGAINST CHIKUNGUNYA VIRUS AND USES THEREOF
    Publication number: 20170015733
    Abstract: The invention relates to binding molecules against Chikungunya virus, which are able of neutralizing Chikungunya virus infectivity, and which can be used with therapeutic, diagnosis or research purposes, as well as to a pharmaceutical composition comprising said binding molecules.
    Type: Application
    Filed: July 29, 2016
    Publication date: January 19, 2017
    Inventors: Lucile Warter, Jean-Pierre Abastado, Alessandra Nardin, Cheng-I Wang
  • Binding molecules against Chikungunya virus and uses thereof
    Patent number: 9441032
    Abstract: The invention relates to binding molecules against Chikungunya virus, which are able of neutralizing Chikungunya virus infectivity, and which can be used with therapeutic, diagnosis or research purposes, as well as to a pharmaceutical composition comprising said binding molecules.
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: September 13, 2016
    Assignee: Agency for Science, Technology and Research
    Inventors: Lucile Warter, Jean-Pierre Abastado, Alessandra Nardin, Cheng-I Wang
  • Binding Molecules Against Chikungunya Virus and Uses Thereof
    Publication number: 20130189279
    Abstract: The invention relates to binding molecules against Chikungunya virus, which are able of neutralizing Chikungunya virus infectivity, and which can be used with therapeutic, diagnosis or research purposes, as well as to a pharmaceutical composition comprising said binding molecules.
    Type: Application
    Filed: April 7, 2011
    Publication date: July 25, 2013
    Applicant: Agency for Science, Technology and Research
    Inventors: Lucile Warter, Jean-Pierre Abastado, Alessandra Nardin, Cheng-I Wang